Mayo Clinic proceedings releases West Nile virus manuscript early to aid clinicians, public

August 18, 2003

ROCHESTER, Minn. -- As the peak transmission season of the West Nile virus reaches its midpoint, Mayo Clinic Proceedings has released via the Web a manuscript prior to publication, so clinicians and the public can quickly access the latest information on the disease.

"Given the recent proliferation of the West Nile virus, clinicians will likely benefit from a brief, well-organized review of the latest data on the epidemiology, clinical presentation, diagnosis and treatment of infections," says William Lanier, M.D., editor-in-chief of Mayo Clinic Proceedings. "To assist with both physician and patient education, the Proceedings has released to its Web site a 'Concise Review for Clinicians' entitled 'West Nile Virus: Epidemiology, Clinical Presentation, Diagnosis and Prevention.' This early release of information to the journal's Web site will precede print publication of the article, which is scheduled for Sept. 1, 2003."

The timing of the early release of the Proceedings review article is in response to a recent, dramatic increase in the rate and geographical distributions of West Nile virus infections. Last year, health officials saw a rapid expansion of the virus when it went from 10 states in 2001 to 39 states, plus Washington, D.C. It caused 284 deaths in 2002 compared to nine in 2001, according to the Centers for Disease Control. In 2003, West Nile virus infections have already been identified in 42 states and, at the current rate of reporting, the number of infections is expected to surpass that of 2002.

The journal's review of the West Nile virus includes the most current epidemiology, virology, transmission, management and prevention of the disease in humans, as well as the disease's effects on animals. There is no specific treatment or vaccine against West Nile virus. The most common way people are infected is through mosquito bites. The mosquitoes become infected when they feed on infected birds. The virus is not transmitted from person to person through mosquito bites. However, five new modes of virus transmission were recognized in 2002, including blood transfusion, organ transplantation, breast-feeding, the placenta of a mother to the fetus, and injuries to laboratory workers.

The review article by Priya Sampathkumar, M.D., a specialist in infectious diseases at Mayo Clinic in Rochester, Minn., can be accessed at http://www.mayo.edu/proceedings/2003/sep/7809crc.pdf. It will be published in the September issue of the journal.
-end-
A peer-reviewed journal, Mayo Clinic Proceedings publishes original articles and reviews dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemiology. Mayo Clinic Proceedings is published monthly by the Mayo Foundation for Medical Education and Research as part of its commitment to the medical education of physicians. The journal has been published for more than 75 years and has a circulation of 130,000 nationally and internationally.

Mayo Clinic

Related West Nile Virus Articles from Brightsurf:

Rising temperatures could shift US West Nile virus transmission
West Nile virus spreads most efficiently in the US at temperatures between 24-25 degrees Celsius (75.2-77 degrees Fahrenheit), a new study published today in eLife shows.

West Nile virus triggers brain inflammation by inhibiting protein degradation
West Nile virus (WNV) inhibits autophagy -- an essential system that digests or removes cellular constituents such as proteins -- to induce the aggregation of proteins in infected cells, triggering cell death and brain inflammation (encephalitis), according to Hokkaido University researchers.

WSU study shows insulin can increase mosquitoes' immunity to West Nile virus
A discovery by a Washington State University-led research team has the potential to inhibit the spread of West Nile virus as well as Zika and dengue viruses.

Critical protein that could unlock West Nile/Zika virus treatments identified
A team of Georgia State scientists has identified a protein that is critical in controlling replication of West Nile and Zika viruses -- and could be important for developing therapies to prevent and treat those viruses.

West Nile virus in the New World: Reflections on 20 years in pursuit of an elusive foe
Though eradication of West Nile virus remains beyond our capability, the body of knowledge built since its arrival in the Americas in 1999 is now powering efforts to minimize its impact and prepare for the invasion of other mosquito-borne diseases.

Light pollution may be increasing West Nile virus spillover from wild birds
House sparrows infected with West Nile virus (WNV) that live in light polluted conditions remain infectious for two days longer than those who do not, increasing the potential for a WNV outbreak by about 41%.

Mount Sinai researchers find significant delays in West Nile virus reporting
Mount Sinai researchers found significant delays in reporting human cases of West Nile virus, hampering real-time forecasting of the potentially deadly mosquito-borne disease, according to a study in the JAMA Network Open in April.

Insecticide resistance genes affect vector competence for West Nile virus
In a context of overuse of insecticides, which leads to the selection of resistant mosquitoes, it is already known that this resistance to insecticides affects interactions between mosquitoes and the pathogens they transmit.

Where will the world's next Zika, West Nile or Dengue virus come from?
Scientists from the University of California, Davis, have identified wildlife species that are the most likely to host flaviviruses such as Zika, West Nile, dengue and yellow fever.

Vanderbilt discovery could neutralize West Nile virus
Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can 'neutralize' the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) in the United States.

Read More: West Nile Virus News and West Nile Virus Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.